Hepalink lower selling price influence profit devote to distribution heparin sodium whole industry chain

Hepalink released a quarterly bulletin today, the first quarter of 2011, the company realized operating income of 678 million yuan, net profit of 152 million yuan, a decline from the same period last year. It was disclosed that the main reason for the decline in the first quarter of the company was the fall in product sales prices. The management of the company admits that the sales price of heparin raw materials will be affected by other factors such as raw material cost, market competition and exchange rate, especially the influence of raw material cost fluctuation of heparin.　　In the overall supply of the company's products in large circumstances, the adjustment of product prices is mainly to maintain long-term competitive advantage and the company's operational strategic arrangements. It is understood that, in addition to heparin API, Hepalink last year has announced that Chengdu Tong Tak joint venture to establish the Chengdu Haitong, into the heparin preparation market. At the same time, the company's 2010 Annual report disclosed that the company has been in China's main origin of pigs in Chengdu, Shandong, the two sides of the crude heparin sodium base construction.　　People familiar with the situation said that the Chengdu Deep Rui and Shandong Rui Sheng, will supply the company 20% to 30% of the heparin crude, Hepalink vertical integration strategy to achieve the initial layout.　　Industry insiders pointed out that heparin drugs due to its extensive market use and the exact clinical efficacy, the future use of the volume is expected to continue to grow steadily, so the future market prospects for heparin raw materials are still broad. Company management said that the company will rely on the current technology in the field of polysaccharide chemical accumulation, research and development of new products. In the next five years, Hepalink will adhere to the development strategy of the integration of heparin industry chain, on the basis of doing strong and big heparin sodium raw materials, and gradually extending to the upstream and downstream of the industrial chain, through the realization of the whole industry chain integration to enhance the company's industry position. Responsible Editor: NF045